Issue 5/2017
Content (9 Articles)
Therapeutic Options in Refractory Diabetic Macular Oedema
- Current Opinion
Sanket U. Shah, Raj K. Maturi
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
- Open Access
- Leading Article
Bruno Geloneze, José Carlos de Lima-Júnior, Lício A. Velloso
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience
- Review Article
Sarah A. Holstein, Philip L. McCarthy
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
- Review Article
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus
- Open Access
- Review Article
David A. Johnson, Philip O. Katz, David Armstrong, Henry Cohen, Brendan C. Delaney, Colin W. Howden, Peter Katelaris, Radu I. Tutuian, Donald O. Castell
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
- Adis Drug Evaluation
Gillian M. Keating
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
- Adis Drug Evaluation
Yahiya Y. Syed